John B McIntyre
John B McIntyre
Alberta Health Services Tom Baker Cancer Centre
Dirección de correo verificada de
Citado por
Citado por
An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging
S Drabycz, G Roldán, P De Robles, D Adler, JB McIntyre, AM Magliocco, ...
Neuroimage 49 (2), 1398-1405, 2010
POLE exonuclease domain mutation predicts long progression-free survival in grade 3 endometrioid carcinoma of the endometrium
B Meng, LN Hoang, JB McIntyre, MA Duggan, GS Nelson, CH Lee, ...
Gynecologic oncology 134 (1), 15-19, 2014
Toxicity from chemoradiotherapy in older patients with glioblastoma multiforme
AE Sijben, JB McIntyre, GB Roldán, JC Easaw, E Yan, PA Forsyth, ...
Journal of neuro-oncology 89, 97-103, 2008
PIK3CA mutational status and overall survival in patients with cervical cancer treated with radical chemoradiotherapy
JB McIntyre, JS Wu, PS Craighead, T Phan, M Köbel, SP Lees-Miller, ...
Gynecologic oncology 128 (3), 409-414, 2013
Targeted mutation analysis of endometrial clear cell carcinoma
LN Hoang, MK McConechy, B Meng, JB McIntyre, C Ewanowich, CB Gilks, ...
Histopathology 66 (5), 664-674, 2015
A somatic activating NRAS variant associated with kaposiform lymphangiomatosis
SF Barclay, KW Inman, VL Luks, JB McIntyre, A Al-Ibraheemi, AJ Church, ...
Genetics in Medicine 21 (7), 1517-1524, 2019
Morphologic reproducibility, genotyping, and immunohistochemical profiling do not support a category of seromucinous carcinoma of the ovary
PF Rambau, JB McIntyre, J Taylor, S Lee, T Ogilvie, A Sienko, D Morris, ...
The American Journal of Surgical Pathology 41 (5), 685-695, 2017
Population-based study of pseudoprogression after chemoradiotherapy in GBM
GB Roldán, JN Scott, JB McIntyre, M Dharmawardene, PA De Robles, ...
Canadian Journal of Neurological Sciences 36 (5), 617-622, 2009
The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumors
AD Altman, GS Nelson, P Ghatage, JB McIntyre, D Capper, P Chu, ...
Modern Pathology 26 (9), 1255-1263, 2013
Determination of the methylation status of MGMT in different regions within glioblastoma multiforme
MG Hamilton, G Roldán, A Magliocco, JB McIntyre, I Parney, JC Easaw
Journal of neuro-oncology 102, 255-260, 2011
Phosphatidyl inositol-3 kinase (PIK3CA) E545K mutation confers cisplatin resistance and a migratory phenotype in cervical cancer cells
W Arjumand, CD Merry, C Wang, E Saba, JB McIntyre, S Fang, E Kornaga, ...
Oncotarget 7 (50), 82424, 2016
Methylation status of MGMT gene promoter in meningiomas
P De Robles, J McIntyre, S Kalra, G Roldán, G Cairncross, P Forsyth, ...
Cancer genetics and cytogenetics 187 (1), 25-27, 2008
Molecular alterations in indolent, aggressive and recurrent ovarian low‐grade serous carcinoma
JB McIntyre, PF Rambau, A Chan, S Yap, D Morris, GS Nelson, M Köbel
Histopathology 70 (3), 347-358, 2017
PIK3CA missense mutation is associated with unfavorable outcome in grade 3 endometrioid carcinoma but not in serous endometrial carcinoma
JB McIntyre, GS Nelson, P Ghatage, D Morris, MA Duggan, CH Lee, ...
Gynecologic Oncology 132 (1), 188-193, 2014
Specific and sensitive hydrolysis probe-based real-time PCR detection of epidermal growth factor receptor variant III in oral squamous cell carcinoma
JB McIntyre, P Bose, AC Klimowicz, NT Brockton, S Petrillo, W Matthews, ...
PLoS One 7 (2), e31723, 2012
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–15